Our Journey
We measure success by our impact on stroke care, with each milestone reflecting our commitment to innovation and improving patient outcomes.
Rayyan
Therapeutics
2026
Upcoming
Innovations
We are set to launch our next-generation stroke treatment, designed to further extend treatment windows and minimize risks for patients. We’re also expanding our clinical trials to include diverse patient populations to ensure our therapies benefit as many people as possible.
2025
Upcoming
Innovations
In 2025, we successfully completed phase two clinical trials for our novel stroke treatment, showing remarkable results in reducing recovery time and enhancing patient quality of life. This year also saw expanded partnerships with global healthcare leaders, strengthening our position in the stroke treatment space.
2024
Upcoming
Innovations
Our team achieved a major breakthrough in the research of thrombolytic therapy, with preclinical studies demonstrating unprecedented success in safe and effective clot dissolution. This discovery has paved the way for advancing to human trials.
2026
Upcoming
Innovations
We are set to launch our next-generation stroke treatment, designed to further extend treatment windows and minimize risks for patients. We’re also expanding our clinical trials to include diverse patient populations to ensure our therapies benefit as many people as possible.
2025
Upcoming
Innovations
In 2025, we successfully completed phase two clinical trials for our novel stroke treatment, showing remarkable results in reducing recovery time and enhancing patient quality of life. This year also saw expanded partnerships with global healthcare leaders, strengthening our position in the stroke treatment space.
2024
Upcoming
Innovations
Our team achieved a major breakthrough in the research of thrombolytic therapy, with preclinical studies demonstrating unprecedented success in safe and effective clot dissolution. This discovery has paved the way for advancing to human trials.
